scPharmaceuticals Inc.
SCPH · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41 | $58 | $76 | $91 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $19 | $14 | $12 | $9 |
| Inventory | $15 | $14 | $14 | $18 |
| Other Curr. Assets | $4 | $4 | $5 | $5 |
| Total Curr. Assets | $79 | $89 | $106 | $123 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $80 | $91 | $108 | $125 |
| Liabilities | – | – | – | – |
| Payables | $4 | $5 | $4 | $5 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $16 | $10 | $11 | $10 |
| Total Curr. Liab. | $20 | $16 | $15 | $15 |
| LT Debt | $53 | $52 | $52 | $52 |
| Deferred Rev, NC | $0 | $28 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $28 | $27 | $27 |
| Total NC Liab. | $81 | $80 | $79 | $79 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $102 | $96 | $94 | $94 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$404 | -$386 | -$366 | -$348 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $383 | $381 | $380 | $378 |
| Total Equity | -$21 | -$5 | $13 | $31 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $80 | $91 | $108 | $125 |
| Net Debt | $13 | -$5 | -$23 | -$39 |